← Evidence map

ArticleJTO clinical and research reports2024

Long-Term Efficacy and Safety of Lorlatinib in Japanese Patients With

Shunsuke Teraoka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2024
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 38434770